Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Colliding dynamical complex network models: biological attractors versus attractors from material physics.

Ma'ayan A.

Biophys J. 2012 Nov 7;103(9):1816-7. doi: 10.1016/j.bpj.2012.09.019. No abstract available.

2.

Predictive models and computational toxicology.

Knudsen T, Martin M, Chandler K, Kleinstreuer N, Judson R, Sipes N.

Methods Mol Biol. 2013;947:343-74. doi: 10.1007/978-1-62703-131-8_26. Review.

PMID:
23138916
3.

Personal omics profiling reveals dynamic molecular and medical phenotypes.

Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, Miriami E, Karczewski KJ, Hariharan M, Dewey FE, Cheng Y, Clark MJ, Im H, Habegger L, Balasubramanian S, O'Huallachain M, Dudley JT, Hillenmeyer S, Haraksingh R, Sharon D, Euskirchen G, Lacroute P, Bettinger K, Boyle AP, Kasowski M, Grubert F, Seki S, Garcia M, Whirl-Carrillo M, Gallardo M, Blasco MA, Greenberg PL, Snyder P, Klein TE, Altman RB, Butte AJ, Ashley EA, Gerstein M, Nadeau KC, Tang H, Snyder M.

Cell. 2012 Mar 16;148(6):1293-307. doi: 10.1016/j.cell.2012.02.009.

4.

Predicting adverse drug events using pharmacological network models.

Cami A, Arnold A, Manzi S, Reis B.

Sci Transl Med. 2011 Dec 21;3(114):114ra127. doi: 10.1126/scitranslmed.3002774.

5.

Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers.

Chen EY, Xu H, Gordonov S, Lim MP, Perkins MH, Ma'ayan A.

Bioinformatics. 2012 Jan 1;28(1):105-11. doi: 10.1093/bioinformatics/btr625. Epub 2011 Nov 10.

6.

Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.

Tatonetti NP, Denny JC, Murphy SN, Fernald GH, Krishnan G, Castro V, Yue P, Tsao PS, Kohane I, Roden DM, Altman RB.

Clin Pharmacol Ther. 2011 Jul;90(1):133-42. doi: 10.1038/clpt.2011.83. Epub 2011 May 25. Erratum in: Clin Pharmacol Ther. 2011 Sep;90(3):480. Tsau, P S [corrected to Tsao, P S].

7.

Predictive, personalized, preventive, participatory (P4) cancer medicine.

Hood L, Friend SH.

Nat Rev Clin Oncol. 2011 Mar;8(3):184-7. doi: 10.1038/nrclinonc.2010.227. Review.

PMID:
21364692
8.

A map of human genome variation from population-scale sequencing.

1000 Genomes Project Consortium, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA.

Nature. 2010 Oct 28;467(7319):1061-73. doi: 10.1038/nature09534. Erratum in: Nature. 2011 May 26;473(7348):544. Xue, Yali [added]; Cartwright, Reed A [added]; Altshuler, David L [corrected to Altshuler, David]; Kebbel, Andrew [corrected to Keebler, Jonathan]; Koko-Gonzales, Paula [corrected to Kokko-Gonzales, Paula]; Nickerson, Debbie A [corrected to Nickerson, Deborah A].

9.

Systems pharmacology of arrhythmias.

Berger SI, Ma'ayan A, Iyengar R.

Sci Signal. 2010 Apr 20;3(118):ra30. doi: 10.1126/scisignal.2000723. Erratum in: Sci Signal. 2010;3(121):er5.

10.

KEGG for representation and analysis of molecular networks involving diseases and drugs.

Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M.

Nucleic Acids Res. 2010 Jan;38(Database issue):D355-60. doi: 10.1093/nar/gkp896. Epub 2009 Oct 30.

11.

The human microbiome project.

Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI.

Nature. 2007 Oct 18;449(7164):804-10.

12.

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.

Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR.

Science. 2006 Sep 29;313(5795):1929-35.

13.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Takahashi K, Yamanaka S.

Cell. 2006 Aug 25;126(4):663-76. Epub 2006 Aug 10.

Supplemental Content

Support Center